Genedata Unveils New Japanese Web Site for Expanding Pharma R&D and Life Science Business
News Nov 16, 2009
Genedata has announced its new Japanese web site (www.genedata.jp), which enhances knowledge sharing related to target discovery and integrated biological data management; high throughput screening and high content screening; and biomarker discovery and personalized medicine.
The new Japanese web site closely follows an expansion of Genedata in Japan and supports the growing customer base in Asia. Recently signed customers include Astellas Pharmaceuticals, Asubio, Chugai Pharmaceuticals, Takeda Pharmaceuticals, as well as several other pharmaceutical and biotechnology companies. Academic institutions using Genedata software systems include Hyogo College of Medicine, NCC Japan, RIKEN, and Tokyo University.
The success in Japan correlates directly with the success of Genedata globally; the majority of the top 50 pharmaceuticals use Genedata software systems for large-scale biology applications to improve R&D efficiency.
“We hope that the new Japanese site facilitates easier access to valuable information for our Japanese customers,” said Dr. Othmar Pfannes, CEO of Genedata. “We’ve recently seen significant growth in Japanese business and are committed to further expanding Genedata’s presence in Japan.”
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018